🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SERVICE TWEET: This is a monthly reminder that vegetable oils marked in red are toxic traps. Ditch them now or face long-term inflammatory damage. Thank me later.

🚩Repitan conmigo… ➕Tratar bien al médico ➕Pagar bien al médico ➕Reconocer al médico ————————————- ➕➕➕ES MAS eficiente➕➕➕ ➕➕➕ES MÁS efectivo➕➕➕ ..que abrir más facultades. (PD: Hay más médicos que nunca y menos en la asistencia) CEEM IFMSA-Spain

Oye IMSS  te hablan, pero escucha también SNTSS Jalisco !

💡 ¿Sabías qué es la Red de Datos Oncológicos (ODN)?​ Una red europea que une hospitales y centros oncológicos para compartir información basada en evidencia clínica sobre medicamentos contra el cáncer, garantizando la privacidad y calidad de los datos.​ 🔹 Beneficios clave:

#GU25 @asco #urothelialcancer Elizabeth Plimack MD Matt Galsky NIAGARA 🔴 Durva/gem-cis show significang OS & EFS 🟢 Durva/Ch outperformed Ch irrespective of pCR 🟠 Control arm is not de SOC (ddMVAC) 🔵 Dr Plimack beatifully places NIAGARA in context w other trials! ypT0N0 & 2-year OS

🧬🧬ctDNA is emerging as a powerful biomarker, providing insights into tumor burden, treatment response & resistance. But one size does not fit all—test sensitivity, specificity & clinical goals matter! 🩸🩸New epigenomic tech is boosting detection accuracy. Are we ready for a

COSMIC-313: Final OS Analysis Laurence Albiges Cabo+Nivo+Ipi (C+N+I) maintains PFS & ORR benefits vs. Placebo+N+I in 1L IMDC intermediate/poor risk aRCC. No OS difference between arms 🧬 High M2 macrophage abundance linked to improved OS with C+N+I #GU25 @asco #kidneycancer #cancer

🌟📢🔝🔝🔝🎓 ASCO #GU25 | Adjuvant Therapy in RCC: A Practical Guide Presented by: Laurence Albiges, Gustave Roussy OncoAlert 🔹 👏👏👏🔝Exceptional presentation as always, providing clear guidance on adjuvant therapy in RCC! 🔹 Key insights: ✅ KEYNOTE-564 defines eligible

Another nice slide by Maite Bourlon . Useful in clinics. Time off systemic therapy for major surgical intervention in advanced RCC . Note that Cabozantinib Needs to stop 3 weeks before surgery and Lenvatinib needs to stop one week before surgery. ASCO #GU25.

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium out on The Lancet Oncology sciencedirect.com/science/articl… meta-analysis compared the efficacy and toxicity of isodose and dose-escalated

THROMBOCYTOPENIA (TP) CLASSIFICATION Mechanistic classification (production, destruction, sequestration) has poorly discrimination since most causes fall under destruction. The best way to approach TP is based on clinical context: where/how is the patient presenting?

Así fue el momento en que elementos policiacos interceptaron a hombres armados en la carretera federal 307, entre Playa del Carmen y Cancún. Más información: drvnoticias.com/enfrentamiento…

La mejor manera de espantar la inversión en México.

CONSORT 2025 statement: updated guideline for reporting randomised trials hubs.li/Q03hMZt90

Regular screenings save lives. 🩺 Mammogram – Breast cancer 🧫 Pap Smear – Cervical cancer 🩻 Colonoscopy – Colon cancer 🔍 Skin Check – Skin cancer Take charge of your health—schedule your screening today. #NationalCancerControlMonth #CancerAwareness

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic

Most viewed this week from JAMA Oncology: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. ja.ma/44fFHqa

Vitamin Chart of Health foods #TIC2025

Bookmark it.